Biocon gets EIR from USFDA for manufacturing facility of Sterile Drug

25 Jun 2018 Evaluate

Biocon has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its Sterile Drug Product manufacturing facility in Bangalore, following the USFDA pre-approval inspection of this facility in April/May 2018.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

373.45 -2.55 (-0.68%)
20-Jan-2026 10:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1663.60
Dr. Reddys Lab 1165.00
Cipla 1381.95
Zydus Lifesciences 879.20
Lupin 2160.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×